SIRT3 and atherosclerosis: Therefore, decreased SIRT3 levels may contribute to MI development by: 1) affecting lipid metabolism, inflammation and other pathways, initiating the atherosclerosis; and 2) interfering with fatty acid oxidation, ROS generation and mitochondrial functions, leading to death of cardiomyocytes.